Elizabeth Jo Allin, LLP in Niagara, WI - Psychologist

Elizabeth Jo Allin, LLP is a Psychologist - Clinical based in Niagara, Wisconsin. Elizabeth Jo Allin is licensed to practice in Michigan (license number 6301008714) and her current practice location is 1201 Jackson St, Niagara, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (715) 251-4555.

NPI number for Elizabeth Jo Allin is 1477595270 and her current mailing address is 1201 Jackson St, Niagara, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1477595270.

Contact Information

	Elizabeth Jo Allin, LLP
	1201 Jackson St, Niagara, WI 54151-1233
	(715) 251-4555
	(715) 251-1754

Healthcare Provider's Profile

Full Name	Elizabeth Jo Allin
Gender	Female
Speciality	Psychologist - Clinical
Location	1201 Jackson St, Niagara, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1477595270
Provider Enumeration Date: 06/13/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Elizabeth Jo Allin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477595270	NPI	-	NPPES
982471009899	Other		PREFERRED ONE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TC0700X	Psychologist - Clinical	6301008714 (Michigan)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elizabeth Jo Allin is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Elizabeth Jo Allin, LLP 1201 Jackson St, Niagara, WI 54151-1233 Ph: (715) 251-4555	Elizabeth Jo Allin, LLP 1201 Jackson St, Niagara, WI 54151-1233 Ph: (715) 251-4555

News Archive

Myeloma Canada calls on Quebec government to approve Revlimid as second-line therapy

The Government of Quebec's Ministère de la santé et des services sociaux has approved the addition of Revlimid(R) (lenalidomide) to the Province's Drug Formulary as a third-line therapy for multiple myeloma patients. The cost of the drug will be reimbursed under the Province's medicare system.

GSK3 inhibition protects against gum disease

Treatment with the cell-permeable glycogen synthase kinase -3β-specific enzyme inhibitor SB216763 successfully suppresses alveolar bone loss in mice infected with the main periodontal pathogen, Porphyromonas gingivalis, report researchers.

FDA proposes charging fees to compounding pharmacies to pay oversight costs

The head of the U.S. Food and Drug Administration has proposed charging compounding pharmacies fees to pay for the oversight needed to prevent a recurrence of the meningitis outbreak that killed 50 people and sickened hundreds more.

Chagas parasite infects 18M worldwide, often without detection

Chagas, which is caused by the parasite Trypanosoma cruzi, affects 18 million people worldwide, but is particularly prevalent in Latin American countries, "where a bug called the vinchuga, sometimes known as the kissing bug, transmits the disease," the Atlantic reports. The parasite "remains dormant in peoples' bodies for up to 30 years, until it kills them suddenly by stopping their hearts or rupturing their intestines," the magazine writes.

Natazia tablets receive FDA approval for prevention of pregnancy

Bayer HealthCare Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the prevention of pregnancy.

Elizabeth Jo Allin, LLP - Psychologist in Niagara, WI